Bayer to buy contraceptive firm Conceptus
German healthcare firm Bayer plans to buy US contraceptive maker Conceptus in a $1.1bn deal to increase its range in the female healthcare sector.
Effective June 1st, Bayer MaterialScience is raising its selling prices for aliphatic polyisocyanates in the Europe, Middle East, Africa and Latin America regions by at least 9 percent.